03:48:05 EDT Wed 15 May 2024
Enter Symbol
or Name
USA
CA



C:HUGE - FSD Pharma Inc. Subordinate Voting Shares - http://www.fsdpharma.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HUGE - C  0.50.475·0.501.00.485-0.035-6.749.120850.53  0.53  0.4552.23  0.375May 14May 1415 min RT 2¢
CSE - C0.50.475·0.501.00.485-0.035-6.739.717580.53  0.53  0.4552.23  0.375May 1415 min
NEO ATS - U 0.49-0.03-5.83.0160.53  0.53  0.49May 1415 min
Omega - O 0.49-0.03-5.81.0020.53  0.53  0.49May 1415 min
Chi-X - X 0.475-0.045-8.71.5120.475  0.475  0.475May 1415 min
CX2 - H 0.485-0.035-6.72.0140.51  0.51  0.46May 1415 min
CXD - D 0.5025-0.0175-3.41.7070.5025  0.5025  0.5025May 1415 min
TriAct - M 0.520.26    Sep 11-2015 min

Recent Trades - Last 10 of 85
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:29C0.485-0.03550079 CIBC7 TD SecK
15:58:48C0.485-0.03550079 CIBC1 AnonymousK
15:56:34C0.48-0.042,0007 TD Sec1 AnonymousK
15:37:13C0.475-0.04550079 CIBC1 AnonymousK
15:35:43C0.48-0.0450079 CIBC1 AnonymousK
15:32:59C0.475-0.04550084 ITG841 AnonymousK
15:19:54C0.48-0.0450079 CIBC1 AnonymousK
15:19:15C0.48-0.0450079 CIBC1 AnonymousK
15:16:36C0.48-0.0450080 National Bank1 AnonymousK
15:14:11H0.485-0.03550080 National Bank13 InstinetK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-14 20:12C:HUGE0.485SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-14 20:06C:HUGE0.485SEDAR Interim MD & ASEDAR Interim MD & A
2024-05-07 12:47C:HUGE0.52News ReleaseFSD submits Lucid-MS application for ethics review
2024-04-30 14:04C:HUGE0.57News ReleaseFSD Pharma signs agreement with ASPI to conduct trial
2024-04-25 11:46C:HUGE0.63News ReleaseFSD Pharma talks Celly's partnership with Six+One
2024-04-22 12:08C:HUGE0.63News ReleaseFSD Pharma talks Celly unbuzzd rollout
2024-04-17 13:15C:HUGE0.69News ReleaseFSD Pharma expands pipeline to metabolic disorders
2024-04-15 13:41C:HUGE0.82News ReleaseFSD Pharma defers term loan interest payment for Celly
2024-04-08 02:11C:HUGE0.85News ReleaseFSD Pharma has until Oct. 2 to regain Nasdaq compliance
2024-04-01 21:41C:HUGE0.94SEDAR Annual ReportSEDAR Annual Report
2024-03-28 17:29C:HUGE0.96SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-28 17:03C:HUGE0.96SEDAR MD & ASEDAR MD & A
2024-03-27 12:17C:HUGE0.96News ReleaseFSD Pharma to conduct clinical study with iNGENu
2024-03-11 11:17C:HUGE1.06News ReleaseFSD applies for unbuzzd phase 1b trial approval
2024-02-28 12:56C:HUGE1.28News ReleaseFSD Pharma to settle $637,650 debt with shares
2024-02-26 13:29C:HUGE1.28News ReleaseFSD to conduct unbuzzd clinical trial with Ingenu
2024-02-16 20:02C:HUGE1.12News ReleaseFSD Pharma arranges $11.15M (U.S.) ATM offering
2024-02-06 09:01C:HUGE1.10News ReleaseFSD Pharma ex-CEO Bokhari has appeal request denied
2024-01-29 16:43C:HUGE1.13News ReleaseFSD Pharma appoints Chopra as director
2024-01-16 09:42C:HUGE1.22News ReleaseFSD Pharma sees court deny motion to dismiss lawsuit